Advancements in Cancer Theranostics

This book addresses the recent developments, trends, and challenges of nanosized biomedicine for solid tumors with reference to FDA approved imaging and therapeutic agents.In the last 25 years, about 300 nanosized imaging and therapeutic probes have been registered for clinical trials and only about 25 have qualified the necessary needs of FDA approval. None of the books or articles published so f...